Jindal Medicines Pvt Ltd: Government Tender Analysis

Jindal Medicines Pvt Ltd, an active participant in the Indian public sector procurement ecosystem, has submitted bids for 31 government tenders. This analysis provides a comprehensive overview of their tender performance, financial metrics, and competitive positioning, particularly within the Ministry of Defence. Their tender history reveals patterns in qualification rates, engagement across different bid values, and specialized focus areas. This report highlights strengths, weaknesses, opportunities, and threats, providing actionable strategic recommendations.

From April 2018 to March 2025, Jindal Medicines demonstrated a 3.2% win rate across all bids. The company has successfully secured 1 L1 position, indicating their potential to win more tenders through refined bidding strategies. Their technical qualification rate stands at 100.0%, highlighting strong compliance capabilities. Financially, Jindal Medicines has bid on contracts totaling ₹2,95,89,213.0, securing contracts valued at ₹2,95,89,213.0. Despite a perfect technical qualification rate, the financial health score is rated as 'Critical' at 29.9/100 indicating low win rate, contract value, and bid efficiency.

Their primary engagement is with the Department of Military Affairs, under the Ministry of Defence. Analysis using TenderAI reveals both the strengths and strategic areas for development for Jindal Medicines within the Indian government procurement landscape, offering pathways to improve competitiveness and secure more public sector projects.

Jindal Medicines: Financial Performance Analysis

Yearly Trends